Revenue increased 3.9%
Revenue changed +3.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Revenue changed +3.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed -118.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -27.3% from the comparable as-filed period.
Inventory changed -11.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
SBC / revenue changed -17 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +5.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.